Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
ReEngage Therapeutics Logo
ReEngage Therapeutics Growth Score
88
CB Rank
39505
Heat Score
79
ReEngage Therapeutics is a biopharmaceutical company focused on developing drugs that treat longevity-related diseases.
Founded
obfuscation
PrivateSeed Houston, Texas, United States1-10 www.reengagetx.com/
Biotechnology
Manufacturing
Pharmaceutical
Overview

ReEngage Therapeutics
Total Funding
obfuscation
Growth Score
88
Heat Score
79

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score88
-6 pts
in past quarter
Heat Score 79
8 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
+2 more milestones
See more interactive data and historical milestones on desktop for the best experience

About ReEngage Therapeutics

CB Rank
39505
ReEngage Therapeutics is a biopharmaceutical company focused on developing drugs that treat longevity-related diseases.
Founded
obfuscation
PrivateSeed Houston, Texas, United States1-10 www.reengagetx.com/
Biotechnology
Manufacturing
Pharmaceutical

Funding Rounds

Seed
OBF
in
obfuscation

Details

Legal Name ReEngage Therapeutics
Operating Status Active
Company Type For Profit
Predictions & Insights

Growth Insight

See this Growth Insight
ReEngage Therapeutics is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Runway Speculation

Products & Services

ACSS2 Inhibitor Compounds
Drug compounds targeting ACSS2 enzyme to treat cancer and longevity-related diseases by modifying epigenetic mechanisms.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 1
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed
obfuscation
Seed Round - ReEngage Therapeutics Logo
Seed Round - ReEngage Therapeutics
—
obfuscation
— Seed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10
News

News and Press

News•May 18, 2026
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 9, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Aug 6, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

156
-71.66%
 in past month

IT Spend

$118.1KThis year, ReEngage Therapeutics is projected to spend $118.1K on IT, according to Aberdeen.
Sub-Organizations
Frequently Asked Questions

Where is ReEngage Therapeutics's headquarters? ReEngage Therapeutics is located in Houston, Texas, United States.When was the last funding round for ReEngage Therapeutics? ReEngage Therapeutics closed its last funding round on
obfuscation
from a Seed round.Who are ReEngage Therapeutics's competitors? Alternatives and possible competitors to ReEngage Therapeutics may include Insilico Medicine, BioAge Labs, and  Cambrian Biopharma.How much funding has ReEngage Therapeutics raised to date? ReEngage Therapeutics has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(ccb7a32 1)
|